EGX disclosure regarding the upcoming EGM on 14 October 2020 Regulatory DisclosuresBy adminSeptember 21, 2020
Disclosure to EGX regarding the failure to reach quorum for the company’s EGM Regulatory DisclosuresBy adminSeptember 17, 2020
EGX disclosure regarding the upcoming EGM on 17 September 2020 Regulatory DisclosuresBy adminAugust 26, 2020
Disclosure to EGX regarding the company’s board composition Regulatory DisclosuresBy adminAugust 5, 2020
Rameda notified of Anviziram, Remdesivir-Rameda vial prices by Egyptian Drug Authority, on track to market first Remdesivir-Rameda production in September 2020 Corporate NewsBy adminJuly 20, 2020
